Jimmy Lai joins Acepodia as Chief Financial Officer
Biotechnology platform, Acopedia, recently announced the appointment of Jimmy Lai as their new Chief Financial Officer. Jimmy is a seasoned financial expert with more than 30 years of financial management and capital market experience under his belt. His region of expertise are the US and China.
Jimmy currently serves as an independent director and audit chairperson for multiple NYSE-listed companies.
Acepodia is a private biotechnology platform focused on developing novel, targeted, allogeneic cell therapies to treat cancers. It was founded in 2017 by Dr. Patrick Y. Yang, former EVP of Juno Therapeutics, Roche and Genentech, and by Dr. Sonny Hsiao, UC Berkeley Cell Biologist and inventor of Acepodia’s core technology. The firm is based in San Francisco Bay Area.